SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 411.51 |
| Enterprise Value ($M) | 159.62 |
| Book Value ($M) | 241.45 |
| Book Value / Share | 3.20 |
| Price / Book | 1.70 |
| NCAV ($M) | 220.92 |
| NCAV / Share | 2.93 |
| Price / NCAV | 1.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.25 |
| Current Ratio | 7.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 281.62 |
| Assets | 302.15 |
| Liabilities | 60.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -103.92 |
| Net Income | -108.68 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -79.13 |
| Cash from Investing | 0.00 |
| Cash from Financing | 253.20 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.30 | 7.17 | |
| 13G/A | Commodore Capital Lp | 9.90 | 40.17 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 209,167 | 1,088,777 | 19.21 | |
| 85,891 | 446,736 | 19.23 | |
| 114,212 | 571,673 | 19.98 | |
| 287,858 | 910,450 | 31.62 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
| MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
| MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io